Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 StudyLisa Licitra, Song Qu, Kevin Harrington et al.|Journal of Clinical Oncology|2026Cited by 0